Myalgia-arthralgia syndrome induced by docetaxel in oncology

the wolf disguised as a sheep

Authors

Downloads

Download data is not yet available.

Author Biography

Esther Una Cidon, Department of Medical Oncology, Royal Bournemouth and Christchurch Hospital NHS Foundation Trust

MD, MSc, PhD. Medical Oncologist, Department of Medical Oncology, Royal Bournemouth and Christchurch Hospital NHS Foundation Trust, Bournemouth, United Kingdom.

References

Seguin C, Kovacevich N, Voutsadakis IA. Docetaxel-associated myalgia-arthralgia syndrome in patients with breast cancer. Breast Cancer (Dove Med Press). 2017;9:39-44. doi: 10.2147/BCTT.S124646.

Bono P, Kellokumpu-Lehtinen PL, Alanko T, et al. Docetaxel 100 versus 80 mg/m2 as adjuvant treatments of early breast cancer: an exploratory analysis of a randomised trial. Ann Oncol. 2009;20(3):595-6. doi: 10.1093/annonc/mdn771.

Imai A, Matsunami K, Takagi H, Ichigo S. Proposed medications for taxane-induced myalgia and arthralgia (Review). Oncol Lett. 2012;3(6):1181-1185. doi: 10.3892/ol.2012.651.

Downloads

Published

2018-06-07

How to Cite

1.
Cidon EU. Myalgia-arthralgia syndrome induced by docetaxel in oncology: the wolf disguised as a sheep. Sao Paulo Med J [Internet]. 2018 Jun. 7 [cited 2025 Mar. 9];136(3):270-1. Available from: https://periodicosapm.emnuvens.com.br/spmj/article/view/1342

Issue

Vol. 136 No. 3 (2018)

Section

Letter to the Editor

License

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.